Device / Technology News

RSS

Indoor tanning devices: AADA testifies before FDA panel on needed classification changes and calls for ban

American Academy of Dermatology Association (AADA) President and dermatologist William D. James, MD, FAAD, along with other dermatologists and leading researchers today testified before a Food and Drug Administration (FDA) panel considering changes to the current classification of indoor tanning devices. Currently, the FDA classifies indoor tanning devices as Class 1, the category for items that have minimal potential to cause harm to individuals. Items in Class 1 include adhesive bandages and tongue depressors.

27 Mar 2010

Innovative biotechnology leading to better understanding of complex diseases

As recently stated in the Glenville Democrat, innovative biotechnology is leading to a greater understanding of complex diseases and better tools for diagnosing and treating conditions such as heart disease, cancer and diabetes.

27 Mar 2010

New web site launched to support workers at Ascension Genesys Medical Center

Today, the Interfaith Coalition to Stop Abuses at Ascension, a coalition that includes the Teamsters and workers' rights, religious, social justice and community organizations, launched a new web site, www.StopAscensionAbuses.com.

27 Mar 2010

Emerging Healthcare Solutions completes acquisition of “Dreams” telemedicine technology

Emerging Healthcare Solutions, Inc. announced the Closing of its acquisition of the “Dreams” telemedicine technology today. The Company agreed to pay $800,000 to acquire the rights to this exciting medical communications technology.

27 Mar 2010

NFS to implement Allscripts EHR and Practice Management solution

Allscripts announced today that North Florida Surgeons (NFS) has selected the Allscripts Electronic Health Record (EHR) and Practice Management solution to automate and connect clinical and business functions for their 31 physicians and three mid-level providers.

26 Mar 2010

Neurologix reports net loss of $13.5M for year ended December 31, 2009

Neurologix, Inc., a biotechnology company engaged in the development of innovative therapies for the brain and central nervous system, today announced its financial results for the year ended December 31, 2009.

26 Mar 2010

Inverness Medical Deutschland to distribute MDI's Detect-Ready MRSA assay in key European markets

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Inverness Medical Deutschland GmbH today announced that they have entered into an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the key European markets of Germany, Austria and Switzerland.

26 Mar 2010

Collegium Pharmaceutical files IND for second opioid product using DETERx technology

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has filed an Investigational New Drug application for COL-172, a tamper-resistant, extended-release oral opioid formulation intended to treat moderate to severe pain in individuals who require around-the-clock opioid therapy for an extended period of time.

26 Mar 2010

AngioScore receives FDA marketing clearance for PTA Scoring Balloon Catheter

AngioScore, Inc., a developer of novel angioplasty catheters for use in the treatment of cardiovascular disease, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its AngioSculpt® PTA Scoring Balloon Catheter for dilatation of lesions in renal arteries.

26 Mar 2010

Researchers develop new self-organizing neural networks for application in remote sensing field

Research developed at the Universidad Politécnica de Madrid's School of Computing has brought us a big step closer to the application of self-organizing neural networks in the remote sensing field.

26 Mar 2010

Abnormality on chromosome 17 helps detect breast cancer tumour's response to anthracyclines

British researchers have discovered a new way of detecting which breast cancer patients are going to respond best to chemotherapy that includes anthracycline antibiotics. The study has found that an abnormality on chromosome 17, called CEP17, is not only associated with a worse outcome for patients, but also that its presence is a highly significant indicator that the tumour will respond to anthracyclines. The research will be presented at the European Breast Cancer Conference (EBCC7) Thursday 25th March.

26 Mar 2010

Alere WCH partners with Monica Healthcare

Alere Health, LLC, a leader in personal health support solutions, today announced a partnership between the Alere® Women's & Children's Health Division and UK-based Monica Healthcare Ltd, developers of a groundbreaking wireless, wearable fetal-maternal monitor.

26 Mar 2010

New devices pave way for applications in cardiology and neurology

A team of cardiologists, materials scientists, and bioengineers have created and tested a new type of implantable device for measuring the heart's electrical output that they say is a vast improvement over current devices. The new device represents the first use of flexible silicon technology for a medical application.

26 Mar 2010

Substance abuse treatment services: Routine on-site infectious disease screening necessary

Fewer than half of all substance abuse treatment facilities surveyed nationwide reported that they conduct on-site infectious disease screening, according to a new study sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA).

26 Mar 2010

TechTeam Global renews contract with American Community Mutual Insurance Company

TechTeam Global, Inc.,, a worldwide provider of information technology outsourcing and business process outsourcing services, announced today that it has renewed its contract with American Community Mutual Insurance Company (American Community) to provide a broad range of IT infrastructure outsourcing services.

26 Mar 2010

Global home health management market expanding at CAGR of 10% through 2012

Remote health management is the fastest growing segment of a burgeoning home health management market. However, RHM’s full potential will materialize only if health insurers adopt reimbursement practices that encourage greater physician adoption, concludes Scientia Advisors, a global strategy consulting firm, in its review of the worldwide home health management market released today.

26 Mar 2010

Ease of information capture and recordkeeping will help enable smoother transition to EHR systems

The proven ability of the medical transcription sector to deliver innovative, physician-friendly, and cost-effective solutions to the challenges of electronic health record (EHR) adoption will be the message taken to Capitol Hill by members of the Association for Healthcare Documentation Integrity (AHDI) and the Medical Transcription Industry Association (MTIA) for the organizations’ fifth-annual Advocacy Summit on March 24 in Washington, DC.

26 Mar 2010

CTMS solutions provider TranSenda International acquired by BioClinica

BioClinica™, Inc.,, a global provider of clinical trial management services, today announced its acquisition of substantially all of the assets of privately held TranSenda International, LLC. Headquartered in Bellevue, WA, TranSenda is a provider of clinical trial management software (CTMS) solutions and is a Microsoft Gold Certified Partner.

From Clario 26 Mar 2010

Dell unveils Medical Archiving and PowerEdge C 6100 solutions to boost healthcare efficiency

Dell today unveiled solutions to enable healthcare, higher-education and government organizations to better use technology to manage data, conduct research and fulfill their missions in a more efficient and secure manner.

26 Mar 2010

False perception of increased risk induces women with breast cancer have prophylactic mastectomies

Women who have been diagnosed with breast cancer believe the risk of the disease occurring in their unaffected breast is as much as ten times higher than it actually is. As a result, they are choosing to have prophylactic mastectomies based on a false perception of increased risk, according to new research.

26 Mar 2010

Device / Technology News

Indoor tanning devices: AADA testifies before FDA panel on needed classification changes and calls for ban

Innovative biotechnology leading to better understanding of complex diseases

New web site launched to support workers at Ascension Genesys Medical Center

Emerging Healthcare Solutions completes acquisition of “Dreams” telemedicine technology

NFS to implement Allscripts EHR and Practice Management solution

Neurologix reports net loss of $13.5M for year ended December 31, 2009

Inverness Medical Deutschland to distribute MDI's Detect-Ready MRSA assay in key European markets

Collegium Pharmaceutical files IND for second opioid product using DETERx technology

AngioScore receives FDA marketing clearance for PTA Scoring Balloon Catheter

Researchers develop new self-organizing neural networks for application in remote sensing field

Abnormality on chromosome 17 helps detect breast cancer tumour's response to anthracyclines

Alere WCH partners with Monica Healthcare

New devices pave way for applications in cardiology and neurology

Substance abuse treatment services: Routine on-site infectious disease screening necessary

TechTeam Global renews contract with American Community Mutual Insurance Company

Global home health management market expanding at CAGR of 10% through 2012

Ease of information capture and recordkeeping will help enable smoother transition to EHR systems

CTMS solutions provider TranSenda International acquired by BioClinica

Dell unveils Medical Archiving and PowerEdge C 6100 solutions to boost healthcare efficiency

False perception of increased risk induces women with breast cancer have prophylactic mastectomies

The future of automation: Machine learning–driven hepatocyte and organoid counting

From street to lab: Advancing controlled substance testing with handheld Raman and FTIR

Reimagining light scattering for biotherapeutics

Latest News